Community pharmacies save 20,000 lives during initial vaccination phases
Figures by National Audit Office estimate that programme prevented up to 262,000 hospitalisations
Read More
Author: John Pinching
Data from first DMT-assisted clinical trial revealed
No sign of significant negative effects on anxiety and wellbeing following pioneering Small Pharma trial
Read More
Data delivery: Sanofi and GSK seek authorisation for COVID-19 vaccine
Pharma giants take major stride as vaccine shows significant increase in neutralising antibodies
Read More
Greater tolerance: Allergic reactions to COVID vaccine lower for second dose
Researchers discovered that recipients experiencing an allergic response to second COVID vaccine dose are minimal
Read More
Haleon days: GSK explains demerger decision
New company Haleon will become standalone venture as GSK’s strategy for the future unfolds
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
